We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+5.41%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$6.11B
AUM Growth
+$185M
Cap. Flow
+$561M
Cap. Flow %
9.17%
Top 10 Hldgs %
34.62%
Holding
554
New
150
Increased
91
Reduced
113
Closed
170

Sector Composition

Rank Sector Weight
1 Consumer Staples 21.63%
2 Communication Services 14.26%
3 Industrials 12.74%
4 Consumer Discretionary 10.07%
5 Technology 8.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIRI icon
326
SiriusXM
SIRI
$10B
$274K ﹤0.01%
+5,000
New +$255K
SWFT
327
DELISTED
Swift Transportation Company
SWFT
$273K ﹤0.01%
10,319
-1,002,181
-99% -$24.1M
PLX icon
328
Protalix BioTherapeutics
PLX
$198M
$272K ﹤0.01%
+32,448
New +$305K
SNOW
329
DELISTED
Intrawest Resorts Holdings, Inc.
SNOW
$245K ﹤0.01%
+10,319
New +$245K
EEM icon
330
PUT
iShares MSCI Emerging Markets ETF
EEM
$29.4B
$225K ﹤0.01%
+750,000
New +$30.5M
AMRI
331
DELISTED
Albany Molecular Research Inc
AMRI
$217K ﹤0.01%
+10,000
New +$181K
DIS icon
332
CALL
Walt Disney
DIS
$181B
$211K ﹤0.01%
104,700
+83,700
+399% +$9.17M
KATE
333
DELISTED
Kate Spade & Company
KATE
$186K ﹤0.01%
+10,059
New +$185K
XOM icon
334
CALL
ExxonMobil
XOM
$635B
$170K ﹤0.01%
+326,200
New +$26.7M
XLF icon
335
CALL
State Street Financial Select Sector SPDR ETF
XLF
$58.2B
$148K ﹤0.01%
+400,000
New +$9.49M
HYG icon
336
CALL
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$146K ﹤0.01%
+220,000
New +$19.4M
CHK
337
DELISTED
Chesapeake Energy Corporation
CHK
$122K ﹤0.01%
+122
New +$131K
HYG icon
338
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$115K ﹤0.01%
+1,000,000
New +$88M
CYHHZ
339
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$99K ﹤0.01%
5,055,677
ASH icon
340
CALL
Ashland
ASH
$3.35B
$87K ﹤0.01%
51,900
-38,649
-43% -$2.46M
EPC icon
341
CALL
Edgewell Personal Care
EPC
$1.31B
$83K ﹤0.01%
21,100
-9,500
-31% -$699K
TWX
342
PUT
DELISTED
Time Warner Inc
TWX
$78K ﹤0.01%
+1,735,500
New +$172M
T icon
343
PUT
AT&T
T
$163B
$64K ﹤0.01%
+93,210
New +$2.75M
WBMD
344
CALL
DELISTED
WebMD Health Corp.
WBMD
$61K ﹤0.01%
+45,500
New +$2.54M
VXX
345
PUT
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$60K ﹤0.01%
+50,000
New +$2.89M
MDLZ icon
346
CALL
Mondelez International
MDLZ
$80.3B
$49K ﹤0.01%
200,000
-105,900
-35% -$4.77M
APA icon
347
PUT
APA Corp
APA
$13.3B
$45K ﹤0.01%
+75,000
New +$3.7M
HES
348
CALL
DELISTED
Hess
HES
$42K ﹤0.01%
191,700
-66,900
-26% -$3.13M
C icon
349
CALL
Citigroup
C
$226B
$37K ﹤0.01%
250,000
-500,000
-67% -$30.7M
XLI icon
350
PUT
State Street Industrial Select Sector SPDR ETF
XLI
$33.7B
$21K ﹤0.01%
+300,000
New +$20M

Similar funds

UBS O'Connor's Q2 2017 Portfolio in Review

As of Q2 2017, UBS O'Connor held 554 positions worth $6.11B, up 3.1% from $5.93B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

UBS O'Connor deployed $561M of net new capital in Q2 2017, opening 150 new positions and adding to 91 existing holdings. Its largest new stake was CR Bard Inc.: 886,472 shares worth $280M.

By sector, the portfolio is most concentrated in Consumer Staples at 22% of assets, down from 26% a quarter earlier, followed by Communication Services and Industrials.

On the sell side, the largest reduction was GE Aerospace, an estimated $28.3M trimmed.

  • UBS O'Connor's largest Q2 2017 buy was CR Bard Inc.: 886,472 shares worth $280M.
  • UBS O'Connor added most to Time Warner Inc in Q2 2017, an estimated $82.9M increase.
  • UBS O'Connor's biggest Q2 2017 reduction was GE Aerospace, cutting an estimated $28.3M.
  • UBS O'Connor fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $202M.
  • UBS O'Connor's ten largest holdings make up 35% of its $6.11B portfolio in Q2 2017.
  • UBS O'Connor opened 150 new positions and closed 170 in Q2 2017.
  • UBS O'Connor's portfolio value rose 3.1% quarter-over-quarter to $6.11B.

Based on UBS O'Connor's 13F filing for Q2 2017, filed 14 Aug 2017.